CRVO

NASDAQ · Biotechnology

Cervomed Inc

Penny Stocks Biotech Stocks Healthcare Stocks

$2.73

-0.20 (-6.83%)

As of Aug 15, 2:24 AM ET ·

Analyst Consensus

Strong Buy

Analysts

Moderate

Coverage

Buy 12 92%

Hold 1 8%

Sell 0 0%

Price Target

Analyst Price Target +1,221.6% upside

Low Target $23.71

Average Target $36.08

High Target $52.26

Current Price $2.73

Current
$2.73

Target
$36.08

$23.71 $36.08 avg $52.26

Scenario Analysis

Bear Case

$23.71

768.5%

Low target

Base Case

$36.08

+1,221.6%

Avg target

Bull Case

$52.26

+1,814.3%

High target

Risk/Reward

2.4x

Favorable

Price in Context

52-Week High

$11.25

-75.7% from high

52-Week Low

$2.13

+28.2% from low

Target vs 52W High

$36.08

+220.7% vs high

Next Earnings Report

Aug 17, 2026

tomorrow

EPS Est: $-0.81

Earnings in 1 days. Analyst targets may shift significantly after the report.

Peer Consensus — Biotechnology

Stock	Consensus	Analysts	Buy %	Target	Upside
ABBV Abbvie Inc	Strong Buy	38	82%	$257.58	+3.3%
AMGN Amgen Inc	Hold	43	49%	$190.87	-54.0%
GILD Gilead Sciences Inc	Strong Buy	37	81%	$362.68	+162.1%
VRTX Vertex Pharmaceuticals Inc	Strong Buy	37	81%	$438.34	-13.3%
REGN Regeneron Pharmaceuticals	Buy	37	70%	$76.80	-90.4%
NTRA Natera Inc	Strong Buy	30	87%	$142.91	-53.9%
RVMD Revolution Medicines Inc	Strong Buy	28	93%	$114.11	-44.0%
BIIB Biogen Inc	Buy	43	67%	$91.45	-56.4%